258 related articles for article (PubMed ID: 15780622)
1. Synthesis and anticonvulsant activity of new 2-substituted-5-(2-benzyloxyphenyl)-1,3,4-oxadiazoles.
Zarghi A; Tabatabai SA; Faizi M; Ahadian A; Navabi P; Zanganeh V; Shafiee A
Bioorg Med Chem Lett; 2005 Apr; 15(7):1863-5. PubMed ID: 15780622
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and anticonvulsant activity of new 2-substituted-5- [2-(2-fluorophenoxy)phenyl]-1,3,4-oxadiazoles and 1,2,4-triazoles.
Almasirad A; Tabatabai SA; Faizi M; Kebriaeezadeh A; Mehrabi N; Dalvandi A; Shafiee A
Bioorg Med Chem Lett; 2004 Dec; 14(24):6057-9. PubMed ID: 15546729
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of new 2-substituted-5-(2-benzylthiophenyl)-1,3,4-oxadiazoles as benzodiazepine receptor agonists.
Zarghi A; Faizi M; Shafaghi B; Ahadian A; Khojastehpoor HR; Zanganeh V; Tabatabai SA; Shafiee A
Bioorg Med Chem Lett; 2005 Jun; 15(12):3126-9. PubMed ID: 15876530
[TBL] [Abstract][Full Text] [Related]
4. New GABA-modulating 1,2,4-oxadiazole derivatives and their anticonvulsant activity.
Lankau HJ; Unverferth K; Grunwald C; Hartenhauer H; Heinecke K; Bernöster K; Dost R; Egerland U; Rundfeldt C
Eur J Med Chem; 2007 Jun; 42(6):873-9. PubMed ID: 17303289
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of new 2-substituted-5-[2-(2-halobenzyloxy)phenyl]-1,3,4-oxadiazoles as anticonvulsant agents.
Zarghi A; Hajimahdi Z; Mohebbi S; Rashidi H; Mozaffari S; Sarraf S; Faizi M; Tabatabaee SA; Shafiee A
Chem Pharm Bull (Tokyo); 2008 Apr; 56(4):509-12. PubMed ID: 18379099
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of novel 3-(4-acetyl-5H/methyl-5-substituted phenyl-4,5-dihydro-1,3,4-oxadiazol-2-yl)-2H-chromen-2-ones as potential anticonvulsant agents.
Bhat MA; Siddiqui N; Khan SA
Acta Pol Pharm; 2008; 65(2):235-9. PubMed ID: 18666431
[TBL] [Abstract][Full Text] [Related]
7. A novel series of 2,5-disubstituted 1,3,4-oxadiazoles: synthesis and SAR study for their anticonvulsant activity.
Rajak H; Singour P; Kharya MD; Mishra P
Chem Biol Drug Des; 2011 Feb; 77(2):152-8. PubMed ID: 21266018
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of anticonvulsant and analgesic effects of benzyl- and benzhydryl ureides.
Librowski T; Kubacka M; Meusel M; Scolari S; Müller CE; Gütschow M
Eur J Pharmacol; 2007 Mar; 559(2-3):138-49. PubMed ID: 17250826
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and anticonvulsant activity of substituted oxadiazole and thiadiazole derivatives.
Yar MS; Akhter MW
Acta Pol Pharm; 2009; 66(4):393-7. PubMed ID: 19702171
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, pharmacological evaluation, and docking study of new acridone-based 1,2,4-oxadiazoles as potential anticonvulsant agents.
Mohammadi-Khanaposhtani M; Shabani M; Faizi M; Aghaei I; Jahani R; Sharafi Z; Shamsaei Zafarghandi N; Mahdavi M; Akbarzadeh T; Emami S; Shafiee A; Foroumadi A
Eur J Med Chem; 2016 Apr; 112():91-98. PubMed ID: 26890115
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and pharmacological evaluation of alpha-substituted N-benzylamides of gamma-hydroxybutyric acid with potential GABA-ergic activity. Part 6. Search for new anticonvulsant compounds.
Malawska B; Kulig K; Gajda J; Szczeblewski D; Musiał A; Wieckowski K; Maciag D; Stables JP
Acta Pol Pharm; 2007; 64(2):127-37. PubMed ID: 17665862
[TBL] [Abstract][Full Text] [Related]
12. N-Substituted amino acid N'-benzylamides: synthesis, anticonvulsant, and metabolic activities.
Béguin C; LeTiran A; Stables JP; Voyksner RD; Kohn H
Bioorg Med Chem; 2004 Jun; 12(11):3079-96. PubMed ID: 15142567
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and anticonvulsant activities of 4-N-substituted arylsemicarbazones.
Pandeya SN; Kohli S; Siddique N; Stables JP
Pol J Pharmacol; 2003; 55(4):565-71. PubMed ID: 14581715
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and potential anticonvulsant activity of new N-3-substituted 5,5-cyclopropanespirohydantoins.
Zhu Q; Pan Y; Xu Z; Li R; Qiu G; Xu W; Ke X; Wu L; Hu X
Eur J Med Chem; 2009 Jan; 44(1):296-302. PubMed ID: 18396358
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of new N-substituted-N'-(3,5-di/1,3,5-trimethylpyrazole-4-yl)thiourea/urea derivatives.
Kaymakçioğlu BK; Rollas S; Körceğez E; Aricioğlu F
Eur J Pharm Sci; 2005 Sep; 26(1):97-103. PubMed ID: 15990284
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, anticonvulsant and toxicity evaluation of 2-(1H-indol-3-yl)acetyl-N-(substituted phenyl)hydrazine carbothioamides and their related heterocyclic derivatives.
Siddiqui N; Alam MS; Ahsan W
Acta Pharm; 2008 Dec; 58(4):445-54. PubMed ID: 19103578
[TBL] [Abstract][Full Text] [Related]
17. Preliminary evaluation of anticonvulsant activity and neurotoxicity of some 1,4-substituted piperazine derivatives.
Marona H; Gunia A; Słoczyńska K; Rapacz A; Filipek B; Cegła M; Opoka W
Acta Pol Pharm; 2009; 66(5):571-8. PubMed ID: 19894654
[TBL] [Abstract][Full Text] [Related]
18. Differential contribution of GABA(A) receptor subtypes to the anticonvulsant efficacy of benzodiazepine site ligands.
Fradley RL; Guscott MR; Bull S; Hallett DJ; Goodacre SC; Wafford KA; Garrett EM; Newman RJ; O'Meara GF; Whiting PJ; Rosahl TW; Dawson GR; Reynolds DS; Atack JR
J Psychopharmacol; 2007 Jun; 21(4):384-91. PubMed ID: 17092983
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of some quinoline-2(1H)-one and 1, 2, 4 - triazolo [ 4 , 3 -a ] quinoline derivatives as potent anticonvulsants.
Guan LP; Jin QH; Tian GR; Chai KY; Quan ZS
J Pharm Pharm Sci; 2007; 10(3):254-62. PubMed ID: 17727789
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antipsychotic and anticonvulsant activity of some new substituted oxa/thiadiazolylazetidinonyl/thiazolidinonylcarbazoles.
Kaur H; Kumar S; Vishwakarma P; Sharma M; Saxena KK; Kumar A
Eur J Med Chem; 2010 Jul; 45(7):2777-83. PubMed ID: 20392546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
